Nav: Home

Big data analysis is 'next frontier' in identifying harmful drug interactions

October 10, 2016

WASHINGTON (Oct. 10 2016) -- Coupling data mining of adverse event reports and electronic health records with targeted laboratory experiments, researchers found a way to identify and confirm previously unknown drug interactions, according to a study published today in the Journal of the American College of Cardiology.

Drug-drug interactions account for a significant proportion of side effects and hospitalizations, but they are often very difficult to predict.

Researchers in the new study used the data mining approach to discover that together, two commonly used drugs - a popular over-the-counter medication for heartburn relief and an antibiotic used to prevent and treat infection - were associated with an increased risk of acquired long QT syndrome, which can lead to life-threatening arrhythmias or problems with the way the heart beats.

"Doctors must often rely on a wait-and-see approach to monitor safety when patients are taking multiple medicines. By using large datasets of clinical records available from the Food and Drug Administration and in electronic health records at our hospital, we were able to use data science to accurately identify a previously unexpected interaction from among millions of possibilities, which would not have been suspected using current surveillance methods," said Nicholas Tatonetti, Ph.D., Herbert Irving Assistant Professor, Department of Biomedical Informatics at Columbia University and one of the study's authors.

The researchers chose to investigate QT interval prolongation because of its importance in drug safety and drug development. The QT interval is the measure of the time between the start and the end of the cardiac electrical cycle as recorded by the electrocardiogram. With QT prolongation, it takes longer to transmit electrical signals through the heart muscle, which can lead to serious, even fata, heart rhythm disturbances. "Investigative drugs that have the potential to prolong the QT interval will be withdrawn before they are ever given to a patient; however, no such checks exist for drug-drug interactions and they often go undiscovered for years," said Tatonetti.

Using an algorithm called Latent Signal Detection, researchers scanned data from two independent databases to investigate possible QT interval-prolonging drug-drug interactions: 1.8 million adverse event reports from the U.S. Food and Drug Administration's Adverse Event Reporting System and 1.6 million electrocardiograms from 382,221 patients treated at New York-Presbyterian/CUMC between 1996 and 2014. A computer can evaluate millions of data points all at once and flag the most likely drug-drug interactions.

Even with large amounts of data, the association between the drug combination and the prolonged QT interval does not prove the drugs caused this problem. To get more information, researchers then applied more traditional analyses and laboratory experiments to validate the predictions.

In this study, people taking ceftriaxone (a cephalosporin antibiotic) and lansoprazole (a proton pump inhibitor) were 40 percent more likely to have a QT interval above 500 ms, which is the current FDA-stated threshold of clinical concern. Among men taking both of these drugs, QT intervals were 12ms longer than men who took either drug alone. This trend was then validated by cellular data from the electrophysiology experiment, which found that together these drugs block one of the cardiac ion channel responsible for controlling heart rhythm. White women and men appear to be more sensitive to this interaction.

Interestingly, the interaction identified in the data analysis was specific to lansoprazole and ceftriaxone, and not other cephalosporin antibiotics. Even though they share similar chemical structure and mode of action, Tatonetti said, "our algorithm was able to distinguish between one that would cause this interaction (ceftriaxone) and another that would not (cefuroxime). We tested both in the lab and the algorithm was correct in both cases."

This research comes at a time when an increasing number of Americans are taking multiple prescriptions and over-the-counter medications. All told, nearly 70 percent take at least one prescription drug, and more than half take two, according to a 2013 study published in the Mayo Clinic Proceedings. Among the most commonly prescribed drugs are antibiotics. Twenty percent of patients are on five or more prescription medications. Finding ways to identify potentially harmful interactions is critical.

In an accompanying editorial, Dan M. Roden, M.D., and colleagues wrote that the findings of this study are not robust enough to advise clinicians to avoid this combination in all patients, but it shows that it is important to examine the effects of these drugs individually and in combination in patients.

The editorial said that with an aging population, it is becoming more common for patients to be on multiple medications, making it more important than ever to find a faster data-driven approach to identifying potential interactions among a vast number of possible drug pairs patients could be taking.

"Solving the methodological challenges of developing approaches to systematically leverage these data sources will be a next frontier in identifying and preventing adverse drug reactions," the authors said.

While the new study was limited to common drug combinations prescribed in one hospital system, Tatonetti and his team believe that analyses made possible through wider data sharing can be used to look more extensively at potential drug interactions.

"The analyses are relatively rapid and inexpensive to perform and they focus on drug combinations that are actually used together in clinical practice," Tatonetti said.
-end-
The study was funded by the National Institutes of Health, National Institute of General Medical Sciences.

The American College of Cardiology is a 52,000-member medical society that is the professional home for the entire cardiovascular care team. The mission of the College is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care, offers cardiovascular accreditation to hospitals and institutions, provides professional medical education, disseminates cardiovascular research and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more, visit acc.org.

The Journal of the American College of Cardiology is the most widely read cardiovascular journal in the world and is the top ranked cardiovascular journal for its scientific impact. JACC is the flagship for a family of journals that publish peer-reviewed research on all aspects of cardiovascular disease. JACC: Cardiovascular Interventions, JACC: Cardiovascular Imaging and JACC: Heart Failure also rank among the top ten cardiovascular journals for impact. JACC: Clinical Electrophysiology and JACC: Basic Translational Science are the newest journals in the JACC family. Learn more at JACC.org.

American College of Cardiology

Related Antibiotic Articles:

Why using antibiotic eye drops for pinkeye is the wrong way to go
Using antibiotic eye drops for pinkeye is often the wrong way to go but 60 percent of patients nationwide are getting prescriptions for the common eye infection that typically clears up on its own.
Comparison of antibiotic treatments for cellulitis
Among patients with uncomplicated cellulitis, the use of an antibiotic regimen with activity against MRSA did not result in higher rates of clinical resolution compared to an antibiotic lacking MRSA activity; however, certain findings suggest further research may be needed to confirm these results, according to a study published by JAMA.
Antibiotic therapy for nearly 1 in 4 adults with pneumonia does not work
Approximately one in four (22.1 percent) adults prescribed an antibiotic in an outpatient setting (such as a doctor's office) for community-acquired pneumonia does not respond to treatment, according to a new study presented at the 2017 American Thoracic Society International Conference.
Key to 'superbug' antibiotic resistance discovered
An international study led by Monash University's Biomedicine Discovery Institute has discovered the molecular mechanism by which the potentially deadly superbug 'Golden Staph' evades antibiotic treatment, providing the first important clues on how to counter superbug antibiotic resistance.
Lighting up antibiotic resistance
Carbapenems are among the 'antibiotics of last resort' and can fight infections for which other drugs have long lost their effectiveness.
How to solve a problem like antibiotic resistance
There has been much recent talk about how to target the rising tide of antibiotic resistance across the world, one of the biggest threats to global health today.
Encouraging signs for potential new antibiotic
A study published online today (Feb. 17, 2017) in the Journal of Antimicrobial Chemotherapy, reveals strong evidence that the first in a new class of antibiotic is as effective as an established antimicrobial agent in the fight against infections caused by antibiotic resistant bacteria.
Scientists develop new antibiotic for gonorrhea
Scientists at the University of York have harnessed the therapeutic effects of carbon monoxide-releasing molecules to develop a new antibiotic which could be used to treat the sexually transmitted infection gonorrhea.
Antibiotic resistance just became more complex
Bacteria that are susceptible to antibiotics can survive when enough resistant cells around them are expressing an antibiotic-deactivating factor.
How bacteria survive antibiotic treatment
Multiresistant bacteria scientists around the world are working hard to win the battle against multi-resistant bacteria.

Related Antibiotic Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Setbacks
Failure can feel lonely and final. But can we learn from failure, even reframe it, to feel more like a temporary setback? This hour, TED speakers on changing a crushing defeat into a stepping stone. Guests include entrepreneur Leticia Gasca, psychology professor Alison Ledgerwood, astronomer Phil Plait, former professional athlete Charly Haversat, and UPS training manager Jon Bowers.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".